431
Views
8
CrossRef citations to date
0
Altmetric
Review

New options for combination therapy for advanced non-squamous NSCLC

Pages 1095-1107 | Received 15 May 2019, Accepted 10 Sep 2019, Published online: 19 Sep 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Maria Concetta Nigro, Paola Valeria Marchese, Chiara Deiana, Chiara Casadio, Linda Galvani, Alessandro Di Federico & Andrea De Giglio. (2023) Clinical Utility and Application of Liquid Biopsy Genotyping in Lung Cancer: A Comprehensive Review. Lung Cancer: Targets and Therapy 14, pages 11-25.
Read now
Yang Li, Moyang Lv, Jingting Liu, Jun Ma, Man Liang & Na Zheng. (2021) The Top 100 Most Frequently Cited Publications Concerning Anti-PD-1/PD-L1 Therapy for Lung Cancer: A Bibliometric Analysis. Cancer Management and Research 13, pages 1383-1393.
Read now

Articles from other publishers (5)

Vered Fuchs, Waleed Kian, Rachel Lichtenberg, Jonah M. Cooper, Areen A. Remilah, Daniel Levin, Nir Peled & Laila C. Roisman. (2022) Next-Generation Sequencing Liquid Biopsy-Guided Osimertinib Rechallenge in EGFR-Mutated Advanced Non-Small-Cell Lung Cancer Patients. Clinical Drug Investigation 42:2, pages 185-192.
Crossref
Weilin Meng, Kelly M Mosesso, Kathleen A Lane, Anna R Roberts, Ashley Griffith, Wanmei Ou & Paul R Dexter. (2021) An Automated Line-of-Therapy Algorithm for Adults With Metastatic Non–Small Cell Lung Cancer: Validation Study Using Blinded Manual Chart Review. JMIR Medical Informatics 9:10, pages e29017.
Crossref
Lisa Mustachio & Jason Roszik. (2020) Current Targeted Therapies for the Fight against Non-Small Cell Lung Cancer. Pharmaceuticals 13:11, pages 374.
Crossref
Ramon Andrade de Mello, Nathália Moisés Neves, Hakaru Tadokoro, Giovanna Araújo Amaral, Pedro Castelo-Branco & Victor André de Almeida Zia. (2020) New Target Therapies in Advanced Non-Small Cell Lung Cancer: A Review of the Literature and Future Perspectives. Journal of Clinical Medicine 9:11, pages 3543.
Crossref
Yao Chen, Xiaobin Li, Guifeng Liu, Shifu Chen, Mingyan Xu, Lele Song & Yina Wang. (2020) ctDNA Concentration, MIKI67 Mutations and Hyper-Progressive Disease Related Gene Mutations Are Prognostic Markers for Camrelizumab and Apatinib Combined Multiline Treatment in Advanced NSCLC. Frontiers in Oncology 10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.